• Novavax delays US trials for COVID vaccine and says late-stage study will begin 'in coming weeks'

    1 month ago - By Daily Mail

    Novovax delayed the start of its late-stage US trials for the second time after initially declaring a start date in October and then November due to problems scaling up its manufacturing.
    Read more ...

     

  • AstraZeneca CEO Says Co Likely to Run New Global Trial on COVID-19 Vaccine: Bloomberg News

    AstraZeneca CEO Says Co Likely to Run New Global Trial on COVID-19 Vaccine: Bloomberg News

    1 month ago - By Medscape

    AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine, according to the company's Chief Executive Pascal Soriot, Bloomberg News reported on Thursday.
    Reuters Health Information
    Read more ...

     

  • When and How Will COVID-19 Vaccines Become Available?

    1 month ago - By Medscape

    Pfizer with partner BioNTech and Moderna have released trial data showing their COVID-19 vaccines to be about 95% effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90% effective.
    Reuters Health Information
    Read more ...

     

  • AstraZeneca Will Do More Testing of COVID Vaccine, CEO Says

    1 month ago - By Medscape

    'Now that we've found what looks like a better efficacy, we have to validate this, so we need to do an additional study,' CEO Pascal Soriot said.
    WebMD Health News
    Read more ...